Literature DB >> 12438239

14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s).

Matt Y Liu1, Shengli Cai, Alexsandra Espejo, Mark T Bedford, Cheryl Lyn Walker.   

Abstract

Tuberin, the product of the tuberous sclerosis complex 2 tumor suppressor gene, is a phosphoprotein that negatively regulates phosphatidylinositol 3'-kinase signaling downstream of Akt. Several high stringency 14-3-3 binding sites that overlapped with Akt phosphorylation sites were identified in tuberin in silico. Recognition of tuberin by an alpha-14-3-3 binding site-specific antibody correlated with mitogen-induced phosphorylation of tuberin and recognition of tuberin by an alpha-Akt phosphorylation substrate antibody. Recognition of tuberin by both antibodies was blocked by inhibiting phosphatidylinositol 3'-kinase activity. Using a protein domain microarray, a tuberin peptide containing Ser(939) demonstrated phospho-specific binding to 14-3-3. Glutathione S-transferase pull-down assays with 14-3-3 fusion proteins revealed that all seven 14-3-3 isoforms (beta, gamma, zeta, epsilon, tau, eta, and sigma) could bind tuberin, and this interaction was abrogated by competition with phosphorylated but not unphosphorylated Ser(939) tuberin peptide. Tuberin also coimmunoprecipitated with 14-3-3, confirming the interaction between endogenous 14-3-3 and tuberin. These data establish the presence of functional and overlapping 14-3-3 and Akt recognition site(s) in tuberin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438239

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Tudor, MBT and chromo domains gauge the degree of lysine methylation.

Authors:  Jeesun Kim; Jeremy Daniel; Alexsandra Espejo; Aimee Lake; Murli Krishna; Li Xia; Yi Zhang; Mark T Bedford
Journal:  EMBO Rep       Date:  2006-01-13       Impact factor: 8.807

2.  Structural basis for protein-protein interactions in the 14-3-3 protein family.

Authors:  Xiaowen Yang; Wen Hwa Lee; Frank Sobott; Evangelos Papagrigoriou; Carol V Robinson; J Günter Grossmann; Michael Sundström; Declan A Doyle; Jonathan M Elkins
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-03       Impact factor: 11.205

3.  Akt blocks the tumor suppressor activity of LKB1 by promoting phosphorylation-dependent nuclear retention through 14-3-3 proteins.

Authors:  Ling Liu; Fung-Ming Siu; Chi-Ming Che; Aimin Xu; Yu Wang
Journal:  Am J Transl Res       Date:  2012-04-10       Impact factor: 4.060

4.  Phosphorylation-dependent interaction of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein (YWHA) with PADI6 following oocyte maturation in mice.

Authors:  Alan J Snow; Pawan Puri; Amparo Acker-Palmer; Tewis Bouwmeester; Srinivasan Vijayaraghavan; Douglas Kline
Journal:  Biol Reprod       Date:  2008-05-07       Impact factor: 4.285

5.  Hormone-induced 14-3-3γ adaptor protein regulates steroidogenic acute regulatory protein activity and steroid biosynthesis in MA-10 Leydig cells.

Authors:  Yasaman Aghazadeh; Malena B Rone; Josip Blonder; Xiaoying Ye; Timothy D Veenstra; D Buck Hales; Martine Culty; Vassilios Papadopoulos
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

6.  14-3-3ζ silencing retards tongue squamous cell carcinoma progression by inhibiting cell survival and migration.

Authors:  L M Jin; X H Han; Y Q Jie; S S Meng
Journal:  Cancer Gene Ther       Date:  2016-04-15       Impact factor: 5.987

7.  Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2.

Authors:  Hong Liu; Derek C Radisky; Celeste M Nelson; Hui Zhang; Jimmie E Fata; Richard A Roth; Mina J Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-07       Impact factor: 11.205

8.  Trypanosoma cruzi targets Akt in host cells as an intracellular antiapoptotic strategy.

Authors:  Marina V Chuenkova; Mercio PereiraPerrin
Journal:  Sci Signal       Date:  2009-11-17       Impact factor: 8.192

9.  REDD2 is enriched in skeletal muscle and inhibits mTOR signaling in response to leucine and stretch.

Authors:  Mitsunori Miyazaki; Karyn A Esser
Journal:  Am J Physiol Cell Physiol       Date:  2009-01-07       Impact factor: 4.249

10.  Screening for therapeutic targets of vorinostat by SILAC-based proteomic analysis in human breast cancer cells.

Authors:  Qun Zhou; Raghothama Chaerkady; Patrick G Shaw; Thomas W Kensler; Akhilesh Pandey; Nancy E Davidson
Journal:  Proteomics       Date:  2010-03       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.